← Insider buys
MRNA

Moderna, Inc. · Healthcare

Director Noubar Afeyan sold $1.4M of Moderna, Inc.

Sold$1,369,500
$136.95Price
10,000Shares

What MRNA did after the filing

Filed Sep 2Copier in Sep 6
The stock from Tue, Sep 6 open, $138.00
−2.8%
S&P 500, same days
−5.2%

Measured over 30 trading days, to the Oct 18 close.

Traded Wed, Aug 31. Filed Fri, Sep 2, 7:30 PM ET, after the close. Returns use the Sep 6 open and the Oct 18 close. Not investment advice.